Healthcare · head to head
Clue vs Rx30

Clue
Healthcare
Period and cycle tracking app owned by German company Biowink, positioned around science based tracking and a published stance against sharing data with law enforcement
- From
- Free
- Rated
- -

Rx30
Healthcare
Long-established pharmacy management system for independents and small chains
- From
- On request
- Rated
- -
The short version
- Only Clue has a free tier, so it costs nothing to try first.
- Each has a real cost: Clue clues stated policy on not sharing data with law enforcement without a valid legal process is the companys own published position and legal interpretation, not an independent guarantee, and it can still be compelled to comply with a legally binding request under EU or other applicable law.; Rx30 shares ownership with PioneerRx, so the two are not the independent alternatives a shortlist implies, and roadmap priorities are set centrally
- They diverge on capability: Clue covers Cycle and symptom tracking, Rx30 covers Prescription processing.
- Prices and features above were last checked on 1 September 2026.
Where they differ
Only the attributes on which Clue and Rx30 actually diverge.
Identical on both: user rating (Not yet rated), category (Healthcare).
What each one covers
Drawn from each product's published feature list. An absence here means we hold no record of it - not that the product lacks it.
Only in Clue
- Cycle and symptom tracking
- Cycle insights and patterns
- Research partnerships
- EU-based data hosting
- Fertility and conception mode
- Perimenopause and other life stage tracking
Only in Rx30
- Prescription processing
- Claims adjudication
- Inventory and purchasing
- Point of sale
- Delivery management
- Clinical documentation
What people use each for
The jobs each tool is most often brought in to do.
Clue
- Someone specifically weighing data jurisdiction and legal exposure when choosing a period tracking app, given Clues EU basis and published stance on law enforcement requestsnot Rx30
- A user who wants cycle tracking positioned around scientific research partnerships rather than lifestyle or community contentnot Rx30
- A buyer comparing Clue directly against Flo on current published privacy policy language before choosing which app to trustnot Rx30
- Someone tracking perimenopause or other non-standard cycle stages that some period apps do not support wellnot Rx30
Rx30
- Independent pharmacies and small chains wanting a mature, widely-supported systemnot Clue
- Operations relying on a broad set of wholesaler and PBM interfacesnot Clue
- Pharmacies with significant front-end retail alongside dispensingnot Clue
- Multi-store independents needing consistency across locationsnot Clue
Where each one falls short
Documented limitations, not opinions. Every one is a constraint you would hit in normal use.
Clue
- Clues stated policy on not sharing data with law enforcement without a valid legal process is the companys own published position and legal interpretation, not an independent guarantee, and it can still be compelled to comply with a legally binding request under EU or other applicable law.
- Deeper cycle insights and predictions, the features most likely to justify tracking in the first place, are gated behind the Clue Plus subscription rather than fully free.
- Being a smaller company than some competitors, Clue has less capital and legal resource to contest large-scale legal requests than a larger, better-funded rival might, despite its stated intent to do so.
- Research partnerships using anonymised user data, while opt-in, still mean user-derived data can be used in ways beyond direct app functionality, and users should check current consent settings.
- Cycle predictions rely on self-reported data and general population models, so accuracy for irregular cycles or specific medical conditions remains limited regardless of which app is used.
Rx30
- Shares ownership with PioneerRx, so the two are not the independent alternatives a shortlist implies, and roadmap priorities are set centrally
- The interface shows its age against newer entrants, and this is the most common objection in demonstrations
- Pricing is not published, and total cost including hardware and interfaces needs to be requested explicitly
- Windows-centric, with a cloud story less developed than newer competitors
- US-only, tied to US insurance and regulatory requirements
Pricing, plan by plan
Clue
Free- Clue Plus$9.99/month
- Free tier covers core cycle tracking, logging and basic predictions
- Clue Plus adds deeper cycle insights, extended predictions and personalised content
- Annual Plus plans typically offered at a lower effective monthly rate
Rx30
On request- Rx30$undefined/month
- Prescription processing
- Claims adjudication
- Inventory
Which should you pick?
Choose Clue if
- You need cycle and symptom tracking.
- You want to start without paying.
- You work on iOS, Android.
- You also want cycle insights and patterns.
Choose Rx30 if
- You need prescription processing.
- You work on Windows, Web.
- You also want claims adjudication.
Questions people ask
- Is Clue or Rx30 better?
- Neither clearly leads. Clue starts at Free and Rx30 at On request, and user ratings are close enough to be indistinguishable. Choose on capability and platform support.
- Which is cheaper, Clue or Rx30?
- Clue has a free tier; the other does not. Paid plans start at Free for Clue and On request for Rx30.
- Does Clue or Rx30 run on more platforms?
- Clue runs on iOS, Android. Rx30 runs on Windows, Web.
- Can I use Clue for free?
- Yes. Clue has a free tier, so you can try it without paying. Rx30 starts at On request.
- What is Clue best used for?
- Clue is most often used for someone specifically weighing data jurisdiction and legal exposure when choosing a period tracking app, given clues eu basis and published stance on law enforcement requests, a user who wants cycle tracking positioned around scientific research partnerships rather than lifestyle or community content, a buyer comparing clue directly against flo on current published privacy policy language before choosing which app to trust, someone tracking perimenopause or other non-standard cycle stages that some period apps do not support well. Of those, someone specifically weighing data jurisdiction and legal exposure when choosing a period tracking app, given clues eu basis and published stance on law enforcement requests and a user who wants cycle tracking positioned around scientific research partnerships rather than lifestyle or community content are not what Rx30 is typically brought in for.
- What can Clue do that Rx30 cannot?
- Clue covers Cycle and symptom tracking, Cycle insights and patterns, Research partnerships, EU-based data hosting. Rx30 covers Prescription processing, Claims adjudication, Inventory and purchasing, Point of sale.
Answered from the vendors’ own pages
Clue: Does Clue share data with law enforcement?
Clue publishes a policy stating it does not share health data with law enforcement or public authorities without a legally binding request and states it will challenge requests it considers improper. This is the companys stated position; verify the current policy directly for specifics.
Rx30: Is Rx30 the same company as PioneerRx?
Both are owned by RedSail Technologies. They are sold as separate products to overlapping markets, but roadmap decisions sit with one company, which is worth knowing before treating them as independent options.
Clue: Why does Clue emphasise being an EU company?
Clue operates under EU GDPR data protection rules and states this legal basis makes it harder for authorities outside the EU, including US authorities, to compel data disclosure than for a company based in the US.
Rx30: What does it cost?
Not published. Request the total including hardware, interfaces and training rather than the monthly software fee.
Clue: Is Clue free?
Core cycle tracking, logging and basic predictions are free. Deeper insights and extended predictions require Clue Plus.
Rx30: Why do pharmacies stay on it?
Installed base maturity. The interfaces to wholesalers, PBMs and hardware are long established, and those are the things that quietly stop a pharmacy working when they break.
Rx30: How does it compare to PioneerRx?
PioneerRx is more aggressively developed around clinical services. Rx30 has the larger legacy base and broader front-end retail heritage. Same owner, different emphasis.
Rx30: Is it suitable for a small chain?
Yes, and that is one of its stronger cases. Multi-store consistency is better handled here than by the systems aimed purely at single independents.
Related pages
Other head to heads
- Clue vs Flo
- Clue vs PioneerRx
- Clue vs Rad AI
- Clue vs Therapixel
- Clue vs Athenahealth
- Clue vs Lyra Health
- Clue vs Koa Health
- Clue vs OpenMRS
- Clue vs Visage Imaging
- Clue vs WebPT
- Clue vs Gleamer
- Clue vs Kareo
- Clue vs Quantum Health
- Clue vs Techcyte
- Clue vs TherapyNotes
- Clue vs Zocdoc
- Clue vs Allscripts Professional EHR
- Clue vs Liberty Software
- Clue vs BestRx
- Clue vs Epic Systems
- Clue vs Cerner
- Clue vs Dentrix
- Clue vs eClinicalWorks
- Clue vs GoodRx
- Clue vs Ro
- Clue vs SilverCloud by Amwell
- Clue vs OpenClinica
- Clue vs Bahmni
- Clue vs Beckman Coulter DxONE
- Clue vs Carestream Dental
- Clue vs ChiroTouch
- Clue vs Cerner PowerChart
- Clue vs Cerner PowerWorks
- Rx30 vs Flo
- Rx30 vs PioneerRx
- Rx30 vs Rad AI
- Rx30 vs Therapixel
- Rx30 vs Athenahealth
- Rx30 vs Lyra Health
- Rx30 vs Koa Health
- Rx30 vs OpenMRS
- Rx30 vs Visage Imaging
- Rx30 vs WebPT
- Rx30 vs Gleamer
- Rx30 vs Kareo
- Rx30 vs Quantum Health
- Rx30 vs Techcyte
- Rx30 vs TherapyNotes
- Rx30 vs Zocdoc
- Rx30 vs Allscripts Professional EHR
- Rx30 vs Liberty Software
- Rx30 vs BestRx
- Rx30 vs Epic Systems
- Rx30 vs Cerner
- Rx30 vs Dentrix
- Rx30 vs eClinicalWorks
- Rx30 vs GoodRx
- Rx30 vs Ro
- Rx30 vs SilverCloud by Amwell
- Rx30 vs OpenClinica
- Rx30 vs Bahmni
- Rx30 vs Beckman Coulter DxONE
- Rx30 vs Carestream Dental
- Rx30 vs ChiroTouch
- Rx30 vs Cerner PowerChart
- Rx30 vs Cerner PowerWorks
